Eupraxia Pharmaceuticals's total assets for Q4 2025 were C$85.99M, a decrease of -33.08% from the previous quarter. TSE:EPRX total liabilities were C$5.69M for the fiscal quarter, a 4.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.